- Home
- MOGU vs SONN Comparison
MOGU vs SONN Comparison
Compare MOGU & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- SONN
- Stock Information
- Founded
- MOGU 2011
- SONN N/A
- Country
- MOGU China
- SONN United States
- Employees
- MOGU N/A
- SONN N/A
- Industry
- MOGU Business Services
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- SONN Health Care
- Exchange
- MOGU Nasdaq
- SONN Nasdaq
- Market Cap
- MOGU 19.8M
- SONN 21.4M
- IPO Year
- MOGU 2018
- SONN N/A
- Fundamental
- Price
- MOGU $4.73
- SONN $5.54
- Analyst Decision
- MOGU
- SONN Strong Buy
- Analyst Count
- MOGU 0
- SONN 1
- Target Price
- MOGU N/A
- SONN $20.00
- AVG Volume (30 Days)
- MOGU 3.6M
- SONN 960.3K
- Earning Date
- MOGU 07-21-2025
- SONN 08-13-2025
- Dividend Yield
- MOGU N/A
- SONN N/A
- EPS Growth
- MOGU N/A
- SONN N/A
- EPS
- MOGU N/A
- SONN N/A
- Revenue
- MOGU $19,462,964.00
- SONN $1,000,000.00
- Revenue This Year
- MOGU N/A
- SONN $5,376.22
- Revenue Next Year
- MOGU N/A
- SONN N/A
- P/E Ratio
- MOGU N/A
- SONN N/A
- Revenue Growth
- MOGU N/A
- SONN 1689.52
- 52 Week Low
- MOGU $1.83
- SONN $1.08
- 52 Week High
- MOGU $8.10
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- MOGU 86.11
- SONN 68.98
- Support Level
- MOGU $2.41
- SONN $2.71
- Resistance Level
- MOGU $8.10
- SONN $6.65
- Average True Range (ATR)
- MOGU 0.47
- SONN 0.67
- MACD
- MOGU 0.28
- SONN 0.28
- Stochastic Oscillator
- MOGU 43.75
- SONN 71.83
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.